calendar
28,950 catalysts · 9,622 approval · 5,000 device 510k · 4,728 grant · 2,809 8k filing · 2,000 device pma · 2,000 device recall
28,950 catalysts · 9,622 approval · 5,000 device 510k · 4,728 grant · 2,809 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: CUBIST PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: CUBIST PHARMS LLC. Form: POWDER. Route: INTRAVENOUS
Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: ELITE LABS INC. Form: TABLET. Route: ORAL
Sponsor: PH HEALTH. Form: FOR SOLUTION. Route: ORAL
Sponsor: LUNDBECK PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: DR REDDYS. Form: FOR SOLUTION. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: FOR SOLUTION. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: FOR SOLUTION. Route: ORAL
Sponsor: LUNDBECK PHARMS LLC. Form: FOR SOLUTION. Route: ORAL
Sponsor: AUCTA. Form: FOR SOLUTION. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: INJECTABLE. Route: INJECTION
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL
Sponsor: INGENUS PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
Sponsor: UMEDICA. Form: TABLET. Route: ORAL
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: MSD MERCK CO. Form: TABLET. Route: ORAL
Sponsor: MSD MERCK CO. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVO. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL
Sponsor: WES PHARMA INC. Form: TABLET. Route: ORAL
Sponsor: WEST-WARD PHARMS INT. Form: INJECTABLE. Route: INJECTION
Sponsor: SPECGX LLC. Form: TABLET. Route: SUBLINGUAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: SECURA. Form: CAPSULE. Route: ORAL
Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: INTL MEDICATION. Form: INJECTABLE. Route: INJECTION
Sponsor: ALVOGEN. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: SPECGX LLC. Form: SOLUTION. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION